| # | Drug | Count |
|---|---|---|
| 0 | LEVOTHYROXINE SODIUM | 78 |
| 1 | SOMATROPIN | 38 |
| 2 | FUROSEMIDE | 37 |
| 3 | LEVOTHYROXINE SODIUM ANHYDROUS | 36 |
| 4 | ALEMTUZUMAB | 34 |
| 5 | ACETAMINOPHEN | 32 |
| 6 | METHYLPREDNISOLONE | 28 |
| 7 | RANITIDINE | 28 |
| 8 | ERGOCALCIFEROL | 27 |
| 9 | DIPHENHYDRAMINE HYDROCHLORIDE | 24 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DICLOXACILLIN SODIUM | 4 | 0.0044 |
| 1 | METHENAMINE HIPPURATE | 3 | 0.0023 |
| 2 | RESMETIROM | 5 | 0.0022 |
| 3 | AMISULPRIDE | 13 | 0.0021 |
| 4 | ALEMTUZUMAB | 34 | 0.0018 |
| 5 | TEPROTUMUMAB | 9 | 0.0015 |
| 6 | HYDROXOCOBALAMIN | 6 | 0.0014 |
| 7 | HYDROCORTISONE SODIUM SUCCINATE | 5 | 0.0013 |
| 8 | OXCARBAZEPINE | 19 | 0.0012 |
| 9 | DIMENHYDRINATE | 13 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 83 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 54 |
| 2 | Loop Diuretic [EPC] | 52 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 46 |
| 4 | Anti-epileptic Agent [EPC] | 40 |
| 5 | Mood Stabilizer [EPC] | 37 |
| 6 | Atypical Antipsychotic [EPC] | 34 |
| 7 | CD52-directed Cytolytic Antibody [EPC] | 34 |
| 8 | Benzodiazepine [EPC] | 30 |
| 9 | Provitamin D2 Compound [EPC] | 27 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thyroid Hormone Receptor beta Agonist [EPC] | 5 | 0.0022 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 34 | 0.0018 |
| 2 | Dopamine-2 Receptor Antagonist [EPC] | 13 | 0.0017 |
| 3 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 9 | 0.0015 |
| 4 | Provitamin D2 Compound [EPC] | 27 | 0.0009 |
| 5 | Progestin Antagonist [EPC] | 4 | 0.0008 |
| 6 | Lipid-based Polyene Antifungal [EPC] | 10 | 0.0008 |
| 7 | Thyroid Hormone Synthesis Inhibitor [EPC] | 7 | 0.0007 |
| 8 | Somatostatin Analog [EPC] | 4 | 0.0006 |
| 9 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 54 | 0.0005 |